🔗 Permalink

Inventor profile of:

Raphael Bar-Or

City:

Denver, Colorado

Country:

United States

Published Applications:

Last publication date:

2022-09-15

Top Assignees for applications by Raphael Bar-Or

The entities that hold a legal rights for patent applications filed by inventor Bar-Or Raphael:

Aytu BioScience, Inc. 11 Englewood, CO United States
Luoxis Diagnostics, Inc. 9 Greenwood Village, CO United States
DMI BIOSCIENCES, INC. 8 Greenwood Village, CO United States
Ampio Pharmaceuticals, Inc. 5 Englewood, CO United States
INSTITUTE FOR MOLECULAR MEDICINE, INC. 4 Englewood, CO United States
INSTITUTE FOR MOLECULAR MEDICINE, INC. 4 Greenwood Village, CO United States
AMPIO PHARMACEUTICALS, INC. 2 Greenwood Village, CO United States
Luoxis Diagnostics, Inc. 2 Englewood, CO United States
DMI LIFE SCIENCES, INC. 2 Greenwood Village, CO United States
DMI ACQUISITION CORP. 2 Greenwood Village, CO United States

Recent patent applications by Bar-Or Raphael

Raphael Bar-Or from Denver, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-09-15

US20220288062A1

Human necessities

TREATMENT OF T-CELL MEDIATED DISEASES

#2 | 2021-04-29

US20210121457A1

Human necessities

Treatment of T-cell mediated diseases

#3 | 2021-03-11

US20210069140A1

Human necessities

Treatment of disease with n-acetyl kynurenine

#4 | 2020-01-30

US20200030321A1

Human necessities

Treatment of T-cell mediated diseases

#5 | 2019-07-04

US20190201360A1

Human necessities

TREATMENT OF DISEASE WITH N-ACETYL KYNURENINE

#6 | 2019-05-23

US20190154653A1

Physics

Determination of fertility potential from the oxidation-reduction potential of a biological sample

#7 | 2018-05-24

US20180140598A1

Human necessities

TREAMENT OF T-CELL MEDIATED DISEASES

#8 | 2017-07-06

US20170191981A1

Physics

Determination of fertility potential from the oxidation-reduction potential of a biological sample

#9 | 2017-03-02

US20170059549A1

Physics

Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

#10 | 2016-11-24

US20160341693A1

Physics

Multiple layer gel

#11 | 2016-10-27

US20160313296A1

Physics

USE OF ORP FOR CHARACTERIZING STROKE PATIENTS

#12 | 2016-10-27

US20160313279A1

Physics

METHODS AND SYSTEMS FOR MEASURING AND USING THE OXIDATION-REDUCTION POTENTIAL OF A BIOLOGICAL SAMPLE

#13 | 2016-10-06

US20160290960A1

Physics

Measurement and uses of oxidative status

#14 | 2016-05-05

US20160123948A1

Physics

Method For Improving Animal Food Product Quality

#15 | 2016-01-21

US20160015705A1

Human necessities

Treatment of T-cell mediated diseases

#16 | 2015-08-06

US20150219588A1

Physics

Method and apparatus for measuring oxidation-reduction potential

#17 | 2014-10-02

US20140291169A1

Physics

Measurement and uses of oxidative status

#18 | 2014-05-01

US20140121158A1

Physics

Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

#19 | 2014-04-24

US20140110273A1

Physics

Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

#20 | 2014-04-24

US20140110257A1

Physics

Method and apparatus for measuring oxidation-reduction potential

#21 | 2014-01-02

US20140004551A1

Physics

Measurement and uses of oxidative status

#22 | 2013-10-24

US20130277232A1

Physics

Oxidation-reduction potential test device including a multiple layer gel

#23 | 2013-07-04

US20130171670A1

Physics

DIAGNOSIS AND MONITORING OF INFLAMMATION, ISCHEMIA AND APPENDICITIS

#24 | 2013-03-28

US20130079284A1

Chemistry; metallurgy

TREATMENT OF T-CELL MEDIATED DISEASES

#25 | 2013-03-21

US20130072684A1

Human necessities

Treatment of T-cell mediated diseases

#26 | 2013-03-21

US20130071448A1

Human necessities

Treatment of T-cell mediated diseases

#27 | 2013-03-21

US20130071436A1

Human necessities

Treatment of T-cell mediated diseases

#28 | 2013-03-14

US20130065839A1

Human necessities

Treatment of T-cell mediated diseases

#29 | 2013-02-21

US20130043142A1

Physics

Method and apparatus for measuring oxidation-reduction potential

#30 | 2012-12-27

US20120325685A1

Physics

Measurement and uses of oxidative status

#31 | 2012-08-30

US20120217173A1

Physics

Method and apparatus for measuring oxidation-reduction potential

#32 | 2012-08-30

US20120217159A1

Physics

Method and apparatus for measuring oxidation-reduction potential

#33 | 2012-01-26

US20120022004A1

Human necessities

Treatment of T-cell mediated diseases

#34 | 2010-10-21

US20100267074A1

Physics

Measurement and uses of oxidative status

#35 | 2010-07-29

US20100190696A1

Human necessities

TREATMENT OF T-CELL MEDIATED DISEASES

#36 | 2010-06-10

US20100144611A1

Human necessities

Treatment of T-cell mediated diseases

#37 | 2010-06-10

US20100143338A1

Human necessities

Treatment of T-cell mediated diseases

#38 | 2010-05-13

US20100120056A1

Physics

DIAGNOSIS AND MONITORING OF DISEASES

#39 | 2009-08-18

US10679699

Diagnosis of multiple sclerosis with diketopiperazines

#40 | 2009-01-01

US20090004686A1

Physics

Measurement and uses of oxidative status

#41 | 2006-09-07

US20060199280A1

Physics

Quantification of proteins

#42 | 2005-06-02

US20050119177A1

Human necessities

Treatment of T-cell mediated diseases

#43 | 2005-01-27

US20050021235A1

Physics

Method and system for optically performing an assay to determine a medical condition

InventorID:

96412 ⎘